https://ir.volition.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_18c183a7b720c8677f23ccd3cd6b911e/volitionrx/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.volition.com/news-events/press-releases/detail/891/volitionrx-announces-pricing-of-4-6-million-public-offering Sun, 07 Jun 26 18:30:00 -0400 https://ir.volition.com/news-events/press-releases/detail/891/volitionrx-announces-pricing-of-4-6-million-public-offering https://ir.volition.com/news-events/press-releases/detail/890/volitionrx-files-new-patent-protecting-its-nu-q-nets-test-for-ebola-triage-and-treatment-monitoring Wed, 03 Jun 26 08:12:00 -0400 https://ir.volition.com/news-events/press-releases/detail/890/volitionrx-files-new-patent-protecting-its-nu-q-nets-test-for-ebola-triage-and-treatment-monitoring https://ir.volition.com/news-events/press-releases/detail/889/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution-across-27-billion-total-addressable-markets Wed, 27 May 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/889/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution-across-27-billion-total-addressable-markets https://ir.volition.com/news-events/press-releases/detail/888/volitionrx-limited-announces-first-quarter-2026-financial-results-and-business-update Thu, 14 May 26 16:10:00 -0400 https://ir.volition.com/news-events/press-releases/detail/888/volitionrx-limited-announces-first-quarter-2026-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/887/volitionrx-limited-schedules-first-quarter-2026-earnings-conference-call-and-business-update Mon, 11 May 26 08:19:00 -0400 https://ir.volition.com/news-events/press-releases/detail/887/volitionrx-limited-schedules-first-quarter-2026-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/886/volitionrx-announces-submission-of-manuscript-for-nu-q-vet-cancer-test-in-cats Wed, 06 May 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/886/volitionrx-announces-submission-of-manuscript-for-nu-q-vet-cancer-test-in-cats https://ir.volition.com/news-events/press-releases/detail/885/volition-announces-breakthrough-finger-prick-detection-of-nucleosomes-expanding-global-market-potential-for-sepsis-testing Wed, 29 Apr 26 08:17:00 -0400 https://ir.volition.com/news-events/press-releases/detail/885/volition-announces-breakthrough-finger-prick-detection-of-nucleosomes-expanding-global-market-potential-for-sepsis-testing https://ir.volition.com/news-events/press-releases/detail/884/volitionrx-announces-acceptance-of-compliance-plan-by-nyse-american Thu, 23 Apr 26 08:12:00 -0400 https://ir.volition.com/news-events/press-releases/detail/884/volitionrx-announces-acceptance-of-compliance-plan-by-nyse-american https://ir.volition.com/news-events/press-releases/detail/883/volition-launches-rnuq-webshop-broadening-product-range Mon, 20 Apr 26 07:30:00 -0400 https://ir.volition.com/news-events/press-releases/detail/883/volition-launches-rnuq-webshop-broadening-product-range https://ir.volition.com/news-events/press-releases/detail/882/volitionrx-limited-announces-full-fiscal-year-2025-financial-results-and-business-update Tue, 31 Mar 26 16:05:00 -0400 https://ir.volition.com/news-events/press-releases/detail/882/volitionrx-limited-announces-full-fiscal-year-2025-financial-results-and-business-update